Comprehensive historical analysis of global market for Connected Drug Delivery Devices  has thoroughly analyzed in this report. It offers data and insights from 2019-2022, and provides extensive market forecasts from 2023-2032 by region/country and subsectors. It covers the price, sales volume, revenue, historical growth, gross margin, and future outlooks for the Connected Drug Delivery Devices  market.

The Global Connected Drug Delivery Devices Market Size was worth around USD 7.34 billion in 2024 and is predicted to grow to around USD 72.54 billion by 2035 with a compound annual growth rate (CAGR) of 23.15 % from 2025 to 2035. 

The report includes growth prospects in the global Connected Drug Delivery Devices  market by type, application, sub segement and region and QMI has compiled a comprehensive detailed research report to offer insights. The report details consumption in the Healthcare and other sectors. Regional coverage spans North America, Europe, and rest of the world including Asia Pacific.

Leading players of Connected Drug Delivery Devices  including:

• Adherium
• Aptar Pharma
• AstraZeneca
• Becton, Dickinson, and Company
• Bigfoot Biomedical
• Cohero Health
• Eli Lilly and Company
• Insulet Corporation
• Novartis
• Novo Nordisk
• Phillips Medisize
• Propeller Health
• Teva Pharmaceuticals
• West Pharmaceutical Services 
• Others  

Request To Download Free Sample copy of the report @ https://www.sphericalinsights.com/request-sample/4492

Market split by Segement, can be divided into:

By Type

• Injectable Devices
• Inhalation Devices
• Others

By Type

• Injectable Devices
• Inhalation Devices
• Others

Market segment by Region/Country including:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

Check discount for this report: https://www.sphericalinsights.com/request-discount/4492

In February 2026, Medtronic officially launched the MiniMed Go Smart MDI system with the Simplera sensor across Europe. This marks the first integrated solution that combines data from the InPen smart insulin pen and the Simplera™ continuous glucose sensor into a single mobile app. The system provides real-time, actionable insights for people managing diabetes with multiple daily injections (MDI), helping improve glucose control and treatment decisions.

In October 2025, BD (Becton, Dickinson and Company) launched new AI-enabled solutions to strengthen connectivity across healthcare settings. At the core is the BD Incada Connected Care Platform, a scalable, cloud-based ecosystem that unifies data from BD devices, including infusion pumps, patient monitors, and pharmacy robotics, into one intelligent network. The platform debuted alongside the next-generation BD Pyxis Pro Automated Medication Dispensing Solution, enabling enterprise-wide visibility and actionable insights.

Access full Report with Table of Content @ https://www.decisionsadvisors.com/reports/connected-drug-delivery-devices-market

Whats covered in the report?

• 1. Overview of the Connected Drug Delivery Devices  market.
• 2. The current and forecasted regional (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa) market size data for the Connected Drug Delivery Devices  market, based on segement.
• 3. Connected Drug Delivery Devices  Market trends.
• 4. Connected Drug Delivery Devices  Market drivers.
• 5. Analysis of major company profiles.

Reasons to buy this Market Report:

1. Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Connected Drug Delivery Devices  market.
2. Use the SWOT analysis to determine the competitive intensity and therefore attractiveness of the emerging Connected Drug Delivery Devices  Industry.
3. Leading company profiles reveal details of key Connected Drug Delivery Devices  market players emerging five operations and financial performance.
4. Add weight to presentations and pitches by understanding the future growth prospects of the emerging Connected Drug Delivery Devices  market with five year historical forecasts.
5. Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region.
6. Extensive information on factors that will amplify the growth of the Connected Drug Delivery Devices  market over the upcoming seven years
7. Accurate estimation of the global Connected Drug Delivery Devices  market size
8. Exact estimations of the upcoming trends and changes observed in the consumer behavior
9. Growth of the global Connected Drug Delivery Devices  market across the North & South America, EMEA, Asia Pacific, and Latin America
10. Information about Connected Drug Delivery Devices  market growth potential
11. In-depth analysis of the industry’s competitive landscape and detailed information vis-a-vis on various vendors
12. Furnishing of detailed information on the factors that will restrain the growth of the Connected Drug Delivery Devices  market

About the Spherical Insights

Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.

Contact Us:

Company Name: Spherical Insights

Email: sales@sphericalinsights.com

Phone: +1 303 800 4326 (US)

Follow Us: LinkedIn | Facebook | Twitter